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Background: Minimal access valve surgery, both mitral and aortic, may be related to improvement in
speciﬁc post-operative outcomes, therefore may be beneﬁcial for the subgroup of the elderly referred for
valve surgery.
Methods: A systematic literature review identiﬁed several different studies, of which 6 fulﬁlled criteria
for meta-analysis. Outcomes for a total of 1347 patients (675 conventional standard sternotomy and 672
minimally invasive valve surgery) were assessed with a meta-analysis using random effects modeling.
Heterogeneity, subgroup analysis with quality scoring were also assessed. The primary endpoint was
early mortality. Secondary endpoints included intra and post-operative outcomes.
Results: In the context of elderly patients, minimal access valve surgery conferred comparable early
mortality to standard sternotomy (odd ratio (OR) 0.79, CI [0.40,1.56], p ¼ 0.50) with no heterogeneity
(p ¼ 0.13); it was also associated with reduced mechanical intubation time (OR 0.48, CI [0.30,0.78],
p ¼ 0.003) and reduced post-operative length of stay (weighted mean difference (WMD) 2.91, CI
[3.09, 2.74] p < 0.00001), however both cardio-pulmonary bypass time and cross clamp time were
longer (WMD 24.29, CI [22.97, 25.61] p < 0.00001 and WMD 8.61, CI [7.61, 9.61], p < 0.00001, respec-
tively); subgroup analysis demonstrated statistically signiﬁcant reduced post-operative length of stay for
both minimally invasive aortic and mitral surgery (WMD 2.84, CI [3.07, 2.60] p < 0.00001 and
WMD 2.98, CI [3.25, 2.71] p < 0.00001 respectively).
Conclusions: Despite a prolonged cardiopulmonary bypass and cross clamp time, minimally invasive
valve surgery is a safe alternative to standard sternotomy in the elderly, with similar early mortality, and
improvements in intubation time as well as length of stay.
© 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.ydney), 390 Victoria Street,
(S. Emmanuel).
by Elsevier Ltd. All rights reserve1. Introduction
Population ageing is a long-term trend, which began several
decades ago, moreover the ‘very old segment population’ is
growing at a faster pace than any other age segment of thed.
Fig. 1. Search strategy.
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28.7% of the European population by 2080 [1]. It is clear that, in the
future, cardiac surgeons will have to deal with an even larger
number of elderly patients than today. These patients may be more
prone to develop peri-operative adverse events [2], hence strate-
gies that can ameliorate such outcomes are always sought.
Catheter based technologies, while being available, are still
limited to very high-risk or inoperable patients. Nevertheless, car-
diac surgeons have been offering minimally invasive valve surgery
(MIVS), both aortic and mitral, for several years with favorable re-
sults in the general surgical population [3] - these beneﬁts may be
also evident in patients with co-morbidities [4].
Current drawbacks of MIVS consist of an increased incidence of
stroke, aortic dissection, longer cardio-pulmonary bypass (CPB) and
cross clamp time (CCT). Some of the aforementioned drawbacks
may be related to technical reasons and/or learning curve; more-
over, there are no prospective randomized trials so far, comparing
in an unbiased way MIVS and sternotomy (ST) in a context of
elderly. As such, the majority of evidences comes from observa-
tional studies [2].
Aims of this meta-analysis are to identify, in the context of
elderly patients, whether MIVS 1) can be as safe as the counterpart
ST in terms of mortality 2), can be still associated with certain post-
operative beneﬁts as in the general cardiac population despite the
risk of prolonged cardiopulmonary bypass and cross clamp time.
2. Material and methods
2.1. Literature search
Literature search was performed using PubMed, Ovid, Embase,
Medline, and Cochrane databases using the MeSH terms ‘minimally
invasive/access mitral valve’, ‘minimally invasive/access aortic
valve’, and we included in the MeSH entry terms ‘elderly’, ‘old’,
‘frail’, ‘elders’, ‘frail older’, ‘older adults’, ‘septuagenarian’, ‘octoge-
narian’, ‘nonagenarian’. In addition to this, our search was extended
to include the clinicaltirals.gov database and ‘grey’ literature for
further rigor. The ‘related articles’ function in PubMed was also
used to ensure completeness. The literature search commenced on
06/11/2015 and the last date of the search was 1st December 2015
(Fig. 1); ﬁrst paper scrutinized in Pubmed with mesh term ‘mini-
mally invasive/access aortic valve’ was from 1966.
2.2. Inclusion and exclusion criteria
All articles reporting outcomes for MIVS (experimental group)
and ST (control group) were included. Studies were excluded from
the review if: (1) Inconsistency of data did not allow valid extrac-
tion; (2) data was duplicated; (3) if the experimental or control
group was robotic mitral or aortic valve intervention and (4) the
trial/study was carried out on animal models. Based on these
criteria, two assessors (SE, MM) independently selected studies for
further examination by title and abstract review. All potentially
eligible studies were retrieved in full for further evaluation. Any
disagreement was resolved by discussionwith three senior authors
(TA-RC-KF). Statistical concordance testing was performed using
Cohen's Kappa coefﬁcient to measure of inter-rate agreement.
2.3. Data analysis
Two Authors (MM, SE) independently extracted the following
data from each paper using a predeﬁned protocol including: ﬁrst
author; year of publication; study type; number of subjects and
study population demographics. Speciﬁc outcome data was where
possible for the following: (i) Primary endpoints: early mortality(including 30-day or in-hospital mortality) (ii) Secondary end-
points including: cardio pulmonary bypass time, cross clamp time,
re-opening for bleeding, prolonged intubation time (deﬁned as per
more than 48 h), acute renal failure (deﬁned as per creatinine
>200 mg/dl or double the baseline value or need for dialysis),
stroke, TIA, lung complications, post-operative length of stay.
Meta-analysis was performed in line with recommendations
from the Cochrane Collaboration and in accordance with both
PRISMA (Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) and MOOSE (Meta-analysis Of Observational
Studies in Epidemiology) guidelines [5,6]. Analysis was conducted
by use of Review Manager® Version 5.1.7 for Windows (The
Cochrane Collaboration, Software Update, Oxford, UK) and STATA
v.11 statistical analysis software. Data was analyzed using a
weighted DerSimonianeLaird with random effects model. Contin-
uous data were investigated using weighted mean difference
(WMD) as the summary statistic, reported with 95% conﬁdence
intervals (CI). The point estimate of the WMD was considered
statistically signiﬁcant at p < 0.05, if the 95% conﬁdence interval did
not include the value zero. Categorical variables were analyzed
using the odds ratio (OR). An OR of <1 favored the treatment group
and the point estimate of the OR is considered statistically
M. Moscarelli et al. / International Journal of Surgery 33 (2016) 164e171166signiﬁcant at the p < 0.05 level, if the 95% conﬁdence interval does
not include the value 1.
2.4. Heterogeneity
Inter-study heterogeneity was explored using the Chi [2]-sta-
tistic and the I2 value was calculated to quantify the degree of
heterogeneity across trials that could not be attributable to chance
alone. When I2 was more than 50%, signiﬁcant statistical hetero-
geneity was considered to be present. Three strategies were used to
assess data validity and heterogeneity: (1) Subgroup analysis of
higher quality studies (quality score 8); (2) aortic andmitral valve
surgery subgroup analysis (3) funnel plots to evaluate publication
bias.
2.5. Sub-group analysis and quality scoring
Quality assessment of each study was performed by attributing
a quality assessment score using a modiﬁcation of the New-
castleeOttawa scale [6] that included all the 17 EuroSCORE II risk
factors. Studies attaining greater than the median score of 8 (out of
a maximum 17) were deﬁned to have ‘higher matching quality’.
Modiﬁed NewcastleeOttawa scoring criteria are shown in Table 1.
2.6. Risk of bias analysis
A domain-based evaluation of risk of bias was performed in
accordance with the guidelines outlined in the Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0 [7]. Two au-
thors (MM, SE) subjectively reviewed all studies included in this
review and assigned a value of ‘yes’, ‘no’, or ‘unclear’ to the
following questions: (i) Was the allocation sequence adequately
generated? (ii) Was allocation adequately concealed? (iii) Was
there blinding of participants, personnel and outcome assessors?
(iv) Were incomplete outcome data sufﬁciently assessed? (v) Are
reports in the study free of the suggestion of selective outcome
reporting? ‘Risk of bias’ plots were performed using Review Man-
ager® Version 5.1.7 for Windows (The Cochrane Collaboration,
Software Update, Oxford, UK).
2.7. Deﬁnition of ‘elderly’
Deﬁnition of elderly is somewhat arbitrary; the common use of
a calendar age to mark the threshold of old age assumesTable 1
Criteria for quality assessment. Modiﬁed NewcastleeOttawa scoring criteria.
Quality checklist
Selection
1. Assignment for treatment e any criteria reported? (If yes, 1-star)
2. How representative was the reference group (ST) in comparison to the general popul
selection of group was not described)
3. How representative was the reference group (MIVS) in comparison to the general
reference group, 1-star, no star if drawn from a different source or selection of grou
Comparability
Comparability variables: (1) age; (2) gender; (3) renal function; (4) extracardiac arterio
active endocarditis; (9) critical preoperative state; (10) IDDM; (11) NYHA; (12) CCS
(17) combined.
4. Groups comparable for 1, 2, 3, 4, 5, 6, 7, 8, 9 (If yes, 1-star was assigned for each of
5. Groups comparable for 10, 11, 12, 13, 14, 15, 16, 17(If yes, 1-star was
assigned for each of these. No star was assigned if the two groups differed).
Outcome assessment
6. Clearly deﬁned outcome of interest (If yes, 1-star).
7. Follow-up (1-star if described).
IDDM ¼ insulin dependent diabetes mellitus; MIVS ¼ minimally invasive valve surgery;
Comparability includes all the EuroSCORE II risk-factors.equivalence with biological age, yet at the same time, it is generally
accepted that these two are not necessarily synonymous [8].
Nevertheless, all studies included had a mean population age equal
or above 75 years old (y/o) (Table 2) with a total mean age of 79.2 y/
o for both MIVS and ST groups. Thereby studies with a mean age
below 75 y/o were not included [9,10].
2.8. Deﬁnition of ‘minimal access’
Studies that adopted the Society of Thoracic Surgeons (STS)
database deﬁnition of minimally invasive eminimal access cardiac
surgery (as “any procedure not performed with a full sternotomy
and CPB support) [11] were scrutinized in order to understand if
eligible for inclusion in the meta-analysis. Operative strategies of
each studies include are summarized in Table 3.
3. Results
Our search revealed six studies [12e17] fulﬁlling these inclusion
criteria, producing a pooled data set of 1347 patients of whom 672
underwent MIVS and 675 underwent ST (Table 2/3). There was
100% concordance between reviewers equating to a Cohen's kappa
coefﬁcient of k ¼ 1. Three studies were retrospective observational
[14e16] two studies were propensity matched [13,17] and one case
control [12]. One study [14] reported amalgamated primary and
secondary outcomes for minimally invasive mitral and aortic hence
could not be included in the subgroup analysis.
3.1. Primary outcome
A summary of both primary and secondary endpoints is shown
in Table 4. We observed no difference in terms of early mortality
between MIVS and ST, 4.8% ± 2.6 vs 6.4% ± 2.6, p ¼ 0.86 (OR 0.79,
95% CI [0.40, 1.56], p ¼ 0.150) and no heterogeneity was observed
(Chi [2] 8.51, p ¼ 0.13, I2 41%) (Fig. 2a/b).
3.2. Secondary endpoints
Minimal access valve surgery was associated with prolonged
CPB time (WMD 24.29, CI [22.97, 25.61], p < 0.00001) and CCT
(WMD 8.61, CI [7.61, 9.61], p < 0.00001), however as expected for
continuous value, heterogeneity was observed (p < 0.00001 and
0.0005 CPB and CCT respectively). However MIVS led to reduced
need for mechanical ventilation (OR 0.48, 95% CI [0.30, 0.78],ation for aortic/mitral surgery? (If yes, 1 star, no star if the patients were selected or
population for aortic/mitral surgery? (If drawn from the same community as the
p was not described)
pathy; (5) poor mobility; (6) previous cardiac surgery; (7) chronic lung disease; (8)
IV; (13) LV function; (14) recent MI; (15) pulmonary hypertension; (16) urgency;
these. No star was assigned if the groups differed
NYHA¼New York Heart Association; ST ¼ standard sternotomy.
Table 2
Study characteristics.
Author, year
(total patients) study type
Inclusion
criteria
MIVS/
ST (n)
Mean age (y/o) Sex
(female)(n)
Ejection
fraction (%)
Infective
endocarditis (n)
Chronic
renal failure (n)
COPD (n) CCF -
NYHA (n)
Re-do (n)
MIVS ST MIVS ST MIVS ST MIVS ST MIVS ST MIVS ST MIVS ST MIVS ST
Gilmanov 2015 (n ¼ 200)
Propensity matched
a 100§/100 83 ± 2.1 82.5 ± 2.2 64 67 60 (5.8) 55 (10) 1 0 4 3 11 15 2.4 ± 0.6 2.4 ± 0.6 0 2
Kaneko 2013 (n ¼ 105)
Retrospective observational
a 51∞/54 83.3 ± 2.7 82.4 ± 4.6 15 27 55 (10) 57 (10) NS NS 1 4 NS NS 32 (NYHA 3e4) 34 (NYHA 3e4) 51 54
Iribarne 2012 (n ¼ 175)
Retrospective observational
b 70/105 78.6 ± 3.3 79.4 ± 3.9 27 35 51.9 ± 1.2 50.7 ± 1.2 3 4 0 2 4 13 NS NS 0 0
Holzhey 2011 (n ¼ 286)
Propensity matched
b,c 143/143 76 ± 3.9 76 ± 3.6 41 45 58 ± 15 58 ± 15 6 8 NS NS 13 12 NS NS 21 22
Lamelas 2011 (n ¼ 203)
Retrospective observational
a,b 119§/84 79 (6) 80 (60) 72 47 58 (13) 55 (14) NS NS NS NS NS NS 43 (NYHA 3e4) 47 (NYHA 3e4) 20 18
Sharony 2003 (n ¼ 378)
Case control
a 189§,∞/189 75.3 ± 6.4 75.3 ± 6.7 93 136 NS NS NS NS 4 5 25 24 57 (NYHA 3e4) 64 (NYHA 3e4) 32 32
NS ¼ not speciﬁed; MIVS ¼ minimally invasive valve surgery; ST ¼ sternotomy.
Value are expressed as mean ± sd or median and IQR (inter quartile range).
Inclusions: a-aortic valve; b; -mitral valve; c-aortic and mitral; d-associated tricuspid.
§: indicates AVR right mini-thoracotomy.
∞: indicates AVR upper mini-sternotomy.
Table 3
Operative strategies.
Author/year Approach Aortic cannulation site Venous cannulation site Clamping Conversion (n)
Gilmanov 2015 Mini-aortic n ¼ 100 (ST ¼ 100) Right anterior
mini-thoracotomy
(6e7 cm) 2nd intercostal space
Direct aortic cannulation Right femoral vein Direct clamping 2x
Kaneko 2013 Mini-aortic n ¼ 51 (ST ¼ 54) Upper mini-sternotomy Direct aortic cannulation (n ¼ 6)
Axillary artery (n ¼ 34)
Femoral artery (n ¼ 11)
Right femoral vein (n ¼ 48)
Direct RA cannulation (n ¼ 3)
Direct clamping 0
Iribarne 2012 Mini-mitral n ¼ 70 (ST ¼ 105) Right mini-thoracotomy Direct aortic cannulation Right femoral vein Direct clamping 0
Holzhey 2011 Mini-mitral n ¼ 143 (ST ¼ 143) Right mini-thoracotomy Femoral artery cannulation Right femoral vein Direct clamping NS
Lamelas 2011 Mini- aortic/
mitral n ¼ 119 (ST ¼ 84)
Mitral: Right mini-thoracotomy (fourth to ﬁfth IS)
Aortic: Right anterior
mini-thoracotomy (second to third IS)
Femoral artery cannulation Right femoral vein Direct clamping
Fibrillatory
arrest (for re-do)
NS
Sharony 2003 Mini-aortic N ¼ 189 (ST ¼ 189) Right anterior mini-thoracotomy (n ¼ 169)
Upper mini-sternotomy (n ¼ 20)
Direct aortic cannulation (n ¼ 128)
Femoral artery cannulation (n ¼ 41)
Right femoral vein (n ¼ 134)
Direct RA cannulation (n ¼ 55)
Direct clamping NS
IS ¼ intercostal space; NS ¼ non speciﬁed; RA ¼ right atrium.
x ¼ Intention to treat analysis.
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Table 4
Results of overall meta-analysis.
Outcome N Mean difference Overall effect Heterogeneity
Studies MIVS ST Odds ratio 95% CI p Chi2 p I2
Primary outcome
Early Mortality 6 672 675 0.79 0.40, 1.56 0.50 8.51 0.13 41%
Secondary outcomes
CPB timea 6 672 675 24.29 22.97, 25.61 <0.00001 69.28 <0.00001 93%
CCTa 6 672 675 8.61 7.61, 9.61 <0.00001 21.90 0.0005 77%
Stroke/TIA 5 572 575 1.24 0.51, 3.01 0.63 5.33 0.25 25%
Reopening for bleeding 6 672 675 0.48 0.71, 1.89 0.48 4.48 0.48 0%
Prolonged intubationa 3 289 289 0.48 0.30, 0.78 0.003 1.16 0.56 0%
Lung complication 5 553 591 1.41 0.94, 2.09 0.09 3.50 0.48 0%
Acute renal failure 6 672 675 0.42 0.15, 1.13 0.09 13.9 0.02 62%
Total LOSa 6 672 675 2.91 3.09, 2.74 <0.00001 32.49 <0.00001 92%
AV ¼ atrio-ventricle; CCT ¼ cross clamp time; CPB ¼ cardio-pulmonary bypass; LOS ¼ length of stay; MIVS ¼ minimally invasive valve surgery; ST ¼ sternotomy; TIA ¼
transient ischemic attack.
a Denote signiﬁcance.
Fig. 2. (a). Forest plot MIVS vs ST (Overall Early Mortality); (b) Funnel plot MIVS vs ST (Overall Early Mortality).
M. Moscarelli et al. / International Journal of Surgery 33 (2016) 164e171168p ¼ 0.003) with no heterogeneity (p ¼ 0.56) and to reduced post-
operative length of stay (WMD 2.91, CI [3.09, 2.74],
p < 0.00001) nonetheless heterogeneity was observed
(p < 0.00001). There was no signiﬁcant difference with regard to
all the other secondary outcomes considered and heterogeneity
was found only with regards to acute renal failure (p ¼ 0.002)
(Table 4).3.3. Subgroup and quality scoring analysis
Three studies [12,16,17] included speciﬁcally minimally invasive
aortic valve and two studies [13,15] minimally invasive mitral sur-
gery valve and were meta-analyzed separately. One study [14] did
not separate outcomes therefore was not part of the subgroup
analysis. Analysis of both sub-groups did not demonstrate a
Table 7
Quality scoring.
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tality (OR 0.59, CI [0.32, 1.10] p ¼ 0.10 and OR 1.53, CI [0.71, 3.31]
p ¼ 0.28, minimally invasive aortic and mitral valves surgery
respectively) (Tables 5 and 6).
In terms of secondary outcomes, as per overall analysis, both
subgroups were associated to reduced post-operative length of stay
(WMD 2.84, CI [3.07, 2.60], p < 0.00001 and WMD 2.98, CI
[3.25,2.71], p < 0.00001, aortic andmitral surgery respectively);
however, heterogeneity was observed (p < 0.00001) (Tables 5 and
6). Both CPB and CCT were signiﬁcantly prolonged in the mini-
mally invasive mitral subgroup (p < 0.00001 CPB and CCT, with
heterogeneity only for CCT), however no differences were found in
the aortic subgroup (p ¼ 0.65 and 0.50 CPB and CCT respectively
with no heterogeneity).
By using a modiﬁed version of the Newcastle-Ottawa scale, we
assigned 1 point for each EuroSCORE II risk factors included and
comparable in between the two MIVS and ST groups. The overall
quality of studies is outlined in Table 7. All of the 6 studies included
in this review were considered to be of high quality, scoring above
the median of 8 (Table 5) [12e17] thereafter the overall analysis
(Table 4) may be considered high-quality meta-analysis.Authors (no of patients) Selection Comparability Outcome Total
1 2 3 4 5 6 7
Gilmanov 2015 (n ¼ 200) e e e ******** ****** * * 16
Kaneko 2013 (n ¼ 105) e e e **** *** * * 9
Lamelas 2011 (n ¼ 203) e e e ***** ** * e 8
Iribarne 2012 (n ¼ 175) e e e **** ** * * 8
Holzhey 2011 (n ¼ 286) e e e ******* *** * * 12
Sharony 2003 (n ¼ 378) e e e ****** *** ** e 11
Quality scoring system based on EuroSCORE II modiﬁed Newcastle-Ottawa scale.3.4. Heterogeneity assessment: bias exploration
In accordancewith Cochrane guidelines, risk of bias analysis was
performed for all studies included in this review (Fig. 3). Overall,
high level of bias was detected, due to non-randomized, un-blinded
nature of the majority of studies. In addition to established bias
assessment, a score was also given for each of the following: (1)
multicenter trial, (2) propensity matched study and (3) confounderTable 5
Results of minimally invasive aortic valve meta-analysis.
Outcome N Mean difference
Studies MIAVS ST
Primary outcome
Early Mortality 3 340 343
Secondary outcomes
CPB time 3 340 343 1.35
CCT 3 340 343 1.35
Stroke/TIA 2 240 243
Reopening for bleeding 3 340 343
Lung complication 2 340 343
Acute renal failure 3 340 343
Total LOSa 3 340 343 2.84
CCT ¼ cross clamp time; CPB ¼ cardio-pulmonary bypass; LOS ¼ length of stay; MIAVS ¼
attack.
a Denote signiﬁcance.
Table 6
Results of minimally invasive mitral valve meta-analysis.
Outcome N ¼ 2 Mean difference
Studies MIMVS ST
Primary outcome
Early Mortality 213 248
Secondary outcomes
CPB timea 213 248 25.58
CCTa 213 248 9.21
Stroke/TIA 213 248
Reopening for bleeding 213 248
Acute renal failure 213 248
Total LOSa 213 248 2.98
CCT¼ cross clamp time; CPB ¼ cardio-pulmonary bypass; LOS¼ length of stay; MIMVS¼
attack.
a Denote signiﬁcance.adjustment. No study fulﬁlled all 3 of these criteria (Fig. 3). Two
studies were propensity matched [13,17] and one was case control
[12]; however the general level of population comparability be-
tween groups was high even in the retrospective observational
studies as it is shown in the quality scoring analysis (Table 6).
Funnel plots were used to assess for publication bias for all
primary and secondary outcomes. Minor funnel plot asymmetry
was identiﬁed for primary outcome (Fig. 2b); and minor funnel plot
asymmetries were observed for the secondary outcomes: stroke,
TIA, acute renal dysfunction, lung complication, prolonged venti-
lation time, post-operative length-of-stay and re-opening for
bleeding.
3.5. Comment
This meta-analysis compares elderly patients (mean age 79.2 y/
o) undergoing either MIVS or ST and allowed inclusion of 1347
patients whowould be difﬁcult to accumulate prospectively for thisOverall effect Heterogeneity
Odds ratio 95% CI p Chi2 p I2
0.59 0.32, 1.10 0.10 4.07 0.13 51%
4.52,7.22 0.65 0.83 0.66 0%
2.57, 5.27 0.50 1.91 0.38 0%
2.07 0.70, 6.15 0.19 0.22 0.64 0%
1.08 0.53, 2.22 0.83 1.79 0.41 0%
1.40 0.82, 2.38 0.22 0.39 0.82 0%
0.56 0.26, 1.21 0.14 3.66 0.16 45%
3.07, 2.60 <0.00001 54.05 <0.00001 96%
minimally invasive aortic-valve surgery; ST ¼ sternotomy; TIA ¼ transient ischemic
Overall effect Heterogeneity
Odds ratio 95% CI p Chi2 p I2
1.53 0.71, 3.31 0.28 0.72 0.40 0%
23.99, 27.17 <0.00001 31.58 <0.01 84%
8.18, 10.25 <0.00001 0.03 0.86 0%
1.14 0.38, 3.41 0.82 3.51 0.06 72%
1.08 0.53, 2.23 0.48 2.70 0.83 63%
0.78 0.38, 1.62 0.51 1.54 0.22 35%
3.25, 2.71 <0.00001 2.18 0.14 54%
minimally invasive mitral-valve surgery; ST¼ sternotomy; TIA¼ transient ischemic
Fig. 3. Risk of bias assessment.
M. Moscarelli et al. / International Journal of Surgery 33 (2016) 164e171170particular topic. We demonstrated that MIVS is at least as safe as
the standard approach in terms of early mortality, moreover in the
MIVS groups, both aortic andmitral, therewas a signiﬁcant reduced
mechanical ventilation time and post-operative length of stay.
Cardiopulmonary bypass time and CCT were signiﬁcantly higher in
the MIVS, however that has not translated to any adverse events.
Subgroup aortic analysis did not show differences in terms of CPB
and CCT with the counterpart ST and that may be related to the use
of fast-release valve in the Gilmanov series [17] (weight 18.9%).
Beside elderly patients, there was a consistent number of re-do
operation in four series (Table 2) [12e14,16]. In line with previous
meta-analysis on high-risk patients [2], we did not observe any
differences in terms of stroke and both femoral (retrograde) and
central-aortic or axillary (antegrade) were used in the series
(Table 3); however no endo-clamping were used.
The hypothesis of this meta-analysis is that patients in the MIVS
group could have the same chance to survive at surgery as the ST
group, however we expected differences in the secondary out-
comes such as lung function test, lung atelectasis and consequent
chest infection within 2e3 months post discharge which affect
both quality of life and costs favoring the MIVS to the ST group.
However, such outcomes were not consistently reported so could
not be meta-analyzed. Thereby, in a context of elderly, there is the
need of comparative studies MIVS vs ST with particular focus on
early and mid-term post-operative outcomes. If it is possible to
establish that MIVS performs better over ST, then a comparison
against catheter based procedures might be of particular interest.
We acknowledge several limitations of this study. Deﬁnition of
elderly is somewhat conventional, and studies that included pa-
tients above certain calendar age were considered, with no
mention to biological or functional age. As such, the impact of MIVS
on frailty could not be assessed. However, we included studies
where the mean age was 75 y/o or above.
Although a relatively low level of statistical heterogeneity was
observed throughout the analysis, clinical heterogeneity has to be
considered since two different types of surgery were included
(aortic and mitral); however, the common denominator was the
minimally invasive approach.
Similarly, minimally invasive aortic valve surgery included two
different means of access; the right mini-thoracotomy and upper
sternotomy (Table 3). Moreover, in one series fast release valve
were also used. Amongst the 6 studies included, there were no
randomized controlled trials. Although MIVS is associated with asigniﬁcant learning curve and volumeeoutcome relationship, it
was not possible to quantify the impact of this on the outcomes
reported in this study; nevertheless, bias in favor to ST technique
cannot be ruled out. Cost-effective and quality of life analysis could
not be performed. However, in saying that - if we assess cost-
effectiveness from a quicker return to work perspective, then we
would need to consider a younger patient cohort for a rational
analysis.
Another limitation of this study is that it does not includemid or
long-term outcomes.
In conclusion, with this meta-analysis we contribute to
demonstrating that in a context of elderly patients, MIVS, both
aortic andmitral, is a safe alternative to standard sternotomy. There
was no difference in terms of early mortality; additionally, MIMVS
led to improvements in certain post-operative outcomes such as
reduced mechanical ventilation time and reduced post-operative
length of stay. Ultimately, further studies are needed in order to
better investigate pros and cons of MIMV in such a cohort of
patients.
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